_1547095140316.png?format=webp&height=120&width=120){kind=logo}
Cleara - About the company
Cleara is a seed company based in Utrecht (Netherlands), founded in 2017 by Peter. It operates as a Developer of biomarkers and therapies to treat cancer and aging diseases. Cleara has raised $2.5M in funding from FJ Labs and Apollo Health Ventures. The company has 2239 active competitors, including 549 funded and 392 that have exited. Its top competitors include companies like Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics.
Company Details
Developer of biomarkers and therapies to treat cancer and aging diseases. The company has discovered a protein biomarker, FOXO4 targeting FOXO4 proteins (neutralizing Doxorubicin-induced chemotoxicity) to inhibit and induce apoptosis in senescent cells via P53 genes.
- Website
- www.clearabiotech.com/
- Social
Key Metrics
Founded Year
2017
Location
Utrecht, Netherlands
Stage
Seed
Total Funding
$2.5M in 2 rounds
Latest Funding Round
Ranked
307th among 2239 active competitors
Employee Count
10 as on Jun 30, 2026
Similar Companies
Sign up to download Cleara's company profile
Cleara's funding and investors
Cleara has raised a total funding of $2.5M over 2 rounds. Its first funding round was on 2019. Its latest funding round was a Seed round on Sep 28, 2022 for $*****. 4 investors participated in its latest round. Cleara has 7 institutional investors.
Here is the list of recent funding rounds of Cleara:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 28, 2022 | 1217190 | Seed | 9368641 | 2678594 | 7797686 | 3375805 |
2019 | 4815 | Seed | 8520 | 1801 | 6433 |
Access funding benchmarks and valuations. Sign up today!View details of Cleara's funding rounds and investors
Cleara's founders and board of directors
Founder? Claim ProfileThe founders of Cleara is Peter.
Here are the details of Cleara's key team members:
- Peter: Co-Founder & MD of Cleara. Contact Info: 1 email address
View details of Cleara's Founder profiles and Board Members
Cleara's employee count trend
Cleara has 10 employees as of Jun 26. Here is Cleara's employee count trend over the years:
Uncover Cleara's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cleara's Competitors and alternates
Top competitors of Cleara include Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics. Here is the list of Top 10 competitors of Cleara, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcellera Biologics 2012, Vancouver (Canada), Public | AI-enabled platform for antibodies discovery | $115M | 71/100 | |
2nd | Agios Pharmaceuticals 2008, Cambridge (United States), Public | Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism | $120M | 70/100 | |
3rd | _1556184640480.png?devicePixelRatio=2&height=30&width=30){kind=logo} TScan Therapeutics 1995, Boston (United States), Public | Developer of T cell therapies to harness the immune system against cancer | $180M | 70/100 | |
4th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
5th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
6th | _1548143983431.png?devicePixelRatio=2&height=30&width=30){kind=logo} Beijing Jiakesi drug development 2015, Beijing (China), Public | Developer of small molecule based therapeutics for cancer treatment | $55M | 66/100 | |
7th | _1568982092325.png?devicePixelRatio=2&height=30&width=30){kind=logo} Boundless Bio 2018, San Diego (United States), Public | Developer of therapeutics for cancer by targeting ecDNA | $252M | 65/100 | |
8th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
9th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
10th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
307th | _1547095140316.png?devicePixelRatio=2&height=30&width=30){kind=logo} Cleara 2017, Utrecht (Netherlands), Seed | Developer of biomarkers and therapies to treat cancer and aging diseases | $2.5M | 42/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cleara's competitors? Click here to see the top ones
Cleara's Investments and acquisitions
Cleara has made no investments or acquisitions yet.
Reports related to Cleara
Here is the latest report on Cleara's sector:
News related to Cleara
•
•
Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic DiseasesHerald Chronicle•Sep 28, 2022•Cleara, Apollo Health Ventures, Curie Capital, ROM Utrecht Region and 1 other
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cleara
Explore our recently published companies
- Alfresco - London based, 1996 founded, Unfunded company
- Katana Sports - 2022 founded, Unfunded company
- Anand Rathi - Mumbai based, 1994 founded, Public company
- Providence Health & Services - United States based, 1859 founded, Funding Raised company
- Entekhaabco - Kuwait City based, 2019 founded, Unfunded company
- Glovnetics - Gurugram based, 2022 founded, Unfunded company
